Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
July 2009
Features
Literature Review
Antidepressants and Suicide in Adolescents and Adults
A Public Health Experiment with Unintended Consequences?
The addition of black-box warnings to antidepressants may have led to unintended consequences, including a decline in diagnosis and treatment for depression and perhaps even an end to decreasing rates of suicide.
Jack Alan McCain
A Review of Cardiovascular Risks Associated with Medications Used to Treat Type-2 Diabetes Mellitus
Patients with type-2 diabetes face a high risk of heart disease. Although insulin, sulfonylureas, metformin, and thiazolidinediones (TZDs) help with glycemic control, caution is needed when these agents are prescribed for patients with existing cardiovascular disease.
Erin L. St. Onge, PharmD, Carol Anne Motycka, PharmD, and Shannon A. Miller, PharmD
Meeting Highlights
American Society of Clinical Oncology, 45th Annual Meeting
Some of the topics covered at the ASCO sessions included therapies for gastro-intestinal tumors; gastric cancer; chronic myeloid leukemia; advanced melanoma, metastatic breast cancer; and ovarian, fallopian, and peritoneal cancer. A comparison of the effects of letrozole (Femara) and tamoxifen (Nolvadex) on cognitive function in patients with postmenopausal breast cancer is also presented.
Walter Alexander
Pharmaceutical Approval Update
Topics include iloperidone (Fanapt) for the acute treatment of schizophrenia; bromocriptine mesylate tablets (Cycloset) for glycemic control in type-2 diabetes; and tolvaptan (Samsca) for patients with hyponatremia.
Marvin M. Goldenberg, PhD, RPh, MS
P&T Snapshot
Chart Review: Prophylaxis of Pneumocystis Pneumonia at a Large Metropolitan HIV Clinic
An evaluation of electronic medical records was undertaken to determine whether optimal prophylactic therapy was being provided for HIV-infected patients with Pneumocystis pneumonia.
Amesh A. Adalja, MD, and Emanuel N. Vergis, MD, MPH
Departments
Editorial
The Ergonomics of Innovation
David B. Nash, MD, MBA, discusses the “ergonomics of innovation,” encouraging organizations to create something new from existing ideas, breaking down goals into manageable pieces, and making it easier to promote change.
David B. Nash, MD, MBA
Medication Errors
Fentanyl Transdermal Patches
More Protection Needed for Patients and Their Families
Matthew Grissinger, RPh, FASCP, explains how patients can prevent accidental exposure to and misuse of fentanyl transdermal patches.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Obama Team Brings ‘Consumerist,’ Public Interest Attitude to Drug Issues
Stephen Barlas discusses the potential impact of “consumer-centric” and public interest attitudes on health care reform in the Obama administration.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
From Besivance eyedrops to the Qutenza patch, P&T presents the latest studies about FDA approvals, new indications, recalls, and industry updates.
